Phibro Animal Health Co. Forecasted to Earn FY2024 Earnings of $1.13 Per Share (NASDAQ:PAHC)

Phibro Animal Health Co. (NASDAQ:PAHC) – Equities research analysts at Zacks Research lifted their FY2024 EPS estimates for Phibro Animal Health in a research report issued to clients and investors on Tuesday, April 23rd. Zacks Research analyst R. Department now expects that the company will earn $1.13 per share for the year, up from their previous estimate of $1.12. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.12 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2024 earnings at $0.37 EPS, Q2 2025 earnings at $0.34 EPS, Q4 2025 earnings at $0.40 EPS, FY2025 earnings at $1.21 EPS and Q3 2026 earnings at $0.32 EPS.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.06. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. The company had revenue of $249.90 million for the quarter, compared to the consensus estimate of $242.91 million.

Separately, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Tuesday, April 9th.

Phibro Animal Health Stock Up 4.3 %

Shares of Phibro Animal Health stock opened at $13.61 on Wednesday. Phibro Animal Health has a one year low of $9.40 and a one year high of $15.98. The company has a market cap of $551.21 million, a P/E ratio of 37.81, a PEG ratio of 4.83 and a beta of 0.75. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.60 and a current ratio of 3.12. The firm has a fifty day moving average of $12.80 and a two-hundred day moving average of $11.76.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently modified their holdings of PAHC. SG Americas Securities LLC purchased a new stake in Phibro Animal Health during the third quarter worth $126,000. Illinois Municipal Retirement Fund acquired a new stake in Phibro Animal Health in the 3rd quarter valued at about $162,000. Jump Financial LLC purchased a new position in Phibro Animal Health during the 3rd quarter valued at about $198,000. Barclays PLC raised its position in Phibro Animal Health by 59.8% during the third quarter. Barclays PLC now owns 35,638 shares of the company’s stock worth $456,000 after acquiring an additional 13,332 shares during the last quarter. Finally, New York State Common Retirement Fund lifted its holdings in shares of Phibro Animal Health by 20.9% in the third quarter. New York State Common Retirement Fund now owns 69,944 shares of the company’s stock valued at $893,000 after purchasing an additional 12,110 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Wednesday, March 6th were given a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.53%. Phibro Animal Health’s payout ratio is 133.33%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.